ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 239 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q1 2021. The put-call ratio across all filers is 2.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $1,847,016 | -6.6% | 176,074 | +16.9% | 0.00% | 0.0% |
Q3 2023 | $1,978,332 | +3.8% | 150,558 | -0.5% | 0.00% | 0.0% |
Q2 2023 | $1,905,926 | -11.4% | 151,264 | -8.2% | 0.00% | 0.0% |
Q1 2023 | $2,150,693 | -24.9% | 164,804 | +1.6% | 0.00% | -33.3% |
Q4 2022 | $2,862,408 | +13.6% | 162,268 | -1.9% | 0.00% | 0.0% |
Q3 2022 | $2,519,000 | +3.7% | 165,449 | +1.1% | 0.00% | 0.0% |
Q2 2022 | $2,428,000 | -38.5% | 163,725 | -6.6% | 0.00% | 0.0% |
Q1 2022 | $3,949,000 | +24.3% | 175,349 | +1.8% | 0.00% | +50.0% |
Q4 2021 | $3,178,000 | +87.6% | 172,209 | +35.9% | 0.00% | +100.0% |
Q3 2021 | $1,694,000 | -40.7% | 126,701 | -17.9% | 0.00% | -50.0% |
Q2 2021 | $2,856,000 | +20.9% | 154,317 | -1.9% | 0.00% | +100.0% |
Q1 2021 | $2,362,000 | -6.3% | 157,262 | -10.0% | 0.00% | 0.0% |
Q4 2020 | $2,522,000 | +139.3% | 174,647 | +34.9% | 0.00% | 0.0% |
Q3 2020 | $1,054,000 | +30.9% | 129,462 | +8.8% | 0.00% | 0.0% |
Q2 2020 | $805,000 | +1.1% | 118,956 | +5.2% | 0.00% | 0.0% |
Q1 2020 | $796,000 | -53.0% | 113,096 | -34.4% | 0.00% | 0.0% |
Q4 2019 | $1,692,000 | +8.0% | 172,511 | +20.9% | 0.00% | 0.0% |
Q3 2019 | $1,567,000 | -86.8% | 142,698 | -86.1% | 0.00% | -90.9% |
Q2 2019 | $11,901,000 | +590.3% | 1,023,276 | +466.5% | 0.01% | +450.0% |
Q1 2019 | $1,724,000 | +8.1% | 180,622 | +9.2% | 0.00% | 0.0% |
Q4 2018 | $1,595,000 | -31.0% | 165,434 | +2.1% | 0.00% | 0.0% |
Q3 2018 | $2,310,000 | -60.6% | 162,026 | -66.8% | 0.00% | -66.7% |
Q2 2018 | $5,859,000 | -2.5% | 488,246 | +0.3% | 0.01% | 0.0% |
Q1 2018 | $6,011,000 | +85.5% | 486,804 | +118.6% | 0.01% | +100.0% |
Q4 2017 | $3,241,000 | -15.3% | 222,740 | -17.2% | 0.00% | -25.0% |
Q3 2017 | $3,827,000 | +100.8% | 268,947 | +79.9% | 0.00% | +100.0% |
Q2 2017 | $1,906,000 | +2.2% | 149,474 | +1.6% | 0.00% | 0.0% |
Q1 2017 | $1,865,000 | -31.4% | 147,132 | -44.8% | 0.00% | -33.3% |
Q4 2016 | $2,720,000 | -1.2% | 266,429 | +27.6% | 0.00% | 0.0% |
Q3 2016 | $2,752,000 | -14.9% | 208,877 | -17.9% | 0.00% | -25.0% |
Q2 2016 | $3,233,000 | -36.1% | 254,564 | -33.5% | 0.00% | -33.3% |
Q1 2016 | $5,058,000 | -0.5% | 382,859 | +15.9% | 0.01% | 0.0% |
Q4 2015 | $5,081,000 | +29.6% | 330,392 | +4.5% | 0.01% | +20.0% |
Q3 2015 | $3,922,000 | -13.2% | 316,272 | -4.2% | 0.01% | +25.0% |
Q2 2015 | $4,517,000 | +35.0% | 330,254 | +18.1% | 0.00% | +33.3% |
Q1 2015 | $3,345,000 | -16.2% | 279,660 | -10.5% | 0.00% | -25.0% |
Q4 2014 | $3,990,000 | -31.9% | 312,393 | -28.5% | 0.00% | -20.0% |
Q3 2014 | $5,858,000 | +12.0% | 436,620 | +34.0% | 0.01% | +25.0% |
Q2 2014 | $5,230,000 | -11.9% | 325,912 | -1.0% | 0.00% | -33.3% |
Q1 2014 | $5,934,000 | -1.2% | 329,150 | -15.3% | 0.01% | +20.0% |
Q4 2013 | $6,009,000 | +16.7% | 388,751 | +12.3% | 0.01% | 0.0% |
Q3 2013 | $5,149,000 | +23.3% | 346,231 | +7.3% | 0.01% | +25.0% |
Q2 2013 | $4,177,000 | +70.7% | 322,824 | +79.3% | 0.00% | +100.0% |
Q1 2013 | $2,447,000 | – | 180,012 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthCor Management, L.P. | 11,000,000 | $163,570,000 | 8.77% |
Blue Harbour Group | 7,262,346 | $107,991,000 | 8.08% |
RIVULET CAPITAL, LLC | 265,000 | $3,941,000 | 4.12% |
Breithorn Capital Management | 336,760 | $5,008,000 | 2.92% |
EMINENCE CAPITAL, LP | 7,791,132 | $115,854,000 | 2.56% |
Chinook Capital Management | 76,275 | $1,134,000 | 1.73% |
GARGOYLE INVESTMENT ADVISOR L.L.C. | 198,008 | $2,657,000 | 1.64% |
Adirondack Research & Management Inc. | 190,749 | $2,836,000 | 1.63% |
INTREPID CAPITAL MANAGEMENT INC /DE/ | 100,000 | $1,487,000 | 1.05% |
PRICE MICHAEL F | 477,500 | $7,100,000 | 0.94% |